Monday, April 15, 2013

Ambit Biosciences Names Venture Partner To Board

San Diego-based biopharmaceuticals firm Ambit Biosciences announced this morning that it has tapped a venture partner from New Enterprise Associates for a new board member. Ambit said it has named David R. Parkinson, M.D. to its board of directors; Parkinson also serves on the board of Threshold Pharmaceuticals and Zyngenia, in addition to previously sitting on the boards of Facet Biotech. He was previously CEO and President of Nodality become joining NEA.